Q32 Bio Inc expected to post a loss of $1.51 a share - Earnings Preview

Q32 Bio

07/03/2025 13:31

Q32 Bio Inc QTTB.OQ QTTB.O is expected to show no change in quarterly revenue when it reports  results on March 11 (estimated) for the period ending December 31 2024

​LSEG's mean analyst estimate for Q32 Bio Inc is for a loss of $1.51 per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Q32 Bio Inc is $6.00​, above​ its last closing price of $2.33. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-1.40
-1.40
-1.46
Missed
-4
Jun. 30 2024
-1.05
-1.04
-1.42
Missed
-36.2
Mar. 31 2024
-1.42
-2.32
-14.95
Missed
-543.5​
Dec. 31 2023
-5.40
-5.40
-5.04
Beat
6.7
​​Sep. 30 2023
-7.56
-7.56
-10.26
Missed
-35.7
Jun. 30 2023
-8.94
-8.55
-10.98
Missed
-28.4​
Mar. 31 2023
-9.71
-9.54
-9.00
Beat
5.7
Dec. 31 2022
-9.11
-9.07
-10.80
Missed
-19.1

This summary was machine generated March 7 at 13:31 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)